Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSS0393 ointment in adult plaque psoriasis (Phase III)
CTR20261461Phase 3Active
- Sponsor
- Reistone Biopharma
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of RSS0393 in plaque psoriasis, sponsored by Reistone Biopharma. Started Apr 2026; status: active.
02
Drugs
RSS0393
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20261461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261461.